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DEPRESSION AND ANXIETY 26:279–288 (2009)
Research Article
PSYCHOTHERAPY VERSUS THE COMBINATION OF
PSYCHOTHERAPY AND PHARMACOTHERAPY IN THE
TREATMENT OF DEPRESSION: A META-ANALYSIS
Pim Cuijpers, Ph.D.,1 Annemieke van Straten, Ph.D.,1 Lisanne Warmerdam, M.A.,1
and Gerhard Andersson, Ph.D.2,3
Background: A large number of studies have shown that psychological
treatments have significant effects on depression. Although several studies have
examined the relative effects of psychological and combined treatments, this has
not been studied satisfactorily in recent statistical meta-analyses. Method: We
conducted a meta-analysis of randomized studies in which a psychological
treatment was compared to a combined treatment consisting of the same
psychological treatment with a pharmacological therapy. For each of these
studies we calculated the effect size indicating the difference between the
psychological and the combined treatment. Results: All inclusion criteria were
met by 18 studies, with a total of 1,838 subjects. The mean effect size indicating
the difference between psychological and combined treatment was 0.35 (95% CI:
0.240.45; Po0.001), with low heterogeneity. Subgroup analyses indicated
that the difference between psychological and combined treatments was
significantly smaller in studies in which cognitive behavior therapy was
examined. We also found a trend (Po0.1) indicating that the difference
between psychological and combined treatment was somewhat larger in studies
aimed at specific populations (older adults, chronic depression, HIV patients)
than in studies with adults, and in studies in which Trycyclic antidepressants or
SSRIs were examined, compared to studies in which a medication protocol or
another antidepressant was used. At follow-up, no difference between
psychological and combined treatments was found. Conclusion: We conclude
that combined treatment is more effective than psychological treatment alone.
However, it is not clear whether this difference is relevant from a clinical
perspective. Depression and Anxiety 26:279–288, 2009. r 2008 Wiley-Liss,
Inc.
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INTRODUCTION
In the past three decades, at least 160 controlled and
comparative studies have examined the effects of
psychological treatments compared to control condi-
tions and to other treatments.[1] This large number of
studies has clearly shown that most psychological
treatments studied in a trial have large effects on
depression. Psychological treatments that have proved
effective include cognitive-behaviour therapy,[2] beha-
vioural activation treatments,[3] interpersonal psy-
chotherapy,[4] problem-solving treatment[5,6], and life
review for older adults.[7] These treatments are not
only effective in adults with depression, but also in
older adults,[8] in women with postpartum depres-
sion,[9] and in patients with both depression and
general medical disorders, including multiple sclero-
sis,[10], stroke patients,[11] and cancer patients.[12]
Psychological treatments can be delivered effectively
in group format, individual format, or guided self-help
format.[13,14] Probably, the latest contribution to this
list is the provision of treatment via the Internet.[15]
One group of studies has focused on the comparative
effects of psychological and pharmacological treat-
ments. This research has shown that the effects of both
types of treatment are comparable.[16] It is also clear
that a combined treatment is somewhat more effective
than treatment with pharmacotherapy alone.[17,18] It is
not very clear, however, whether combined treatment is
more effective than a psychological treatment alone.
Clinicians often have different views on this, in
particular when it comes to more severe depression
when combined treatments often are recommended
Although several studies have examined the effects of
combined treatment, the results are not entirely
conclusive. Some studies find no significant differ-
ence.[19–21] whereas others have found that combined
treatment is significantly more effective than psycho-
logical treatment alone.[23,24]There are even a few
studies found that psychological treatment alone is
more effective than combined treatment.[25,26]
Because it can be expected that the difference
between psychological and combined treatments are
small, large sample sizes are required to find significant
differences. When small effect sizes are expected in
individual studies, meta-analytical techniques can be
used to integrate the results of individual studies and to
increase the statistical power. Although several sys-
tematic reviews have examined the difference between
psychological and combined treatments,[27,28] this
question has not been examined in recent statistical
meta-analyses using up-to-date methods. For example,
one meta-analysis conducted in this area has included
only a small portion of the available studies (8 of the 18
studies we have identified, see below.[17] This meta-
analysis also focused on several research questions, did
not pool the results of all studies together, and did not
for example conduct subgroup analyses to examine the
characteristics of the studies, which were related to the
differential effects of the psychological and combined
treatments. It did, however, find some indications that
combined treatment was somewhat more effective than
psychological treatment alone. Another small meta-
analysis did examine the comparative effects of
psychological versus combined treatment,[29] but fo-
cused only on the seven studies that examined out-
patients. This study also found that combined
treatment was superior to psychological treatment
alone.
We decided to conduct a new, comprehensive meta-
analysis in which all available studies are included. We
wanted to examine whether the small benefit of
combined treatment, which was found in the earlier
meta-analyses,[17,29] would also be found when the
number of examined studies was increased. Finally, we
wanted to examine whether study characteristics were
related to the relative effects of psychological and
combined treatments.
METHODS
IDENTIFICATION AND SELECTION OF STUDIES
First, we used a large database of studies on the psychological
treatment of depression in general. This database has been described
in detail elsewhere.[3,5,6,8] It was developed through a comprehensive
literature search (from 1966 to December 2007) in which we
examined 7,911 abstracts in Pubmed (1,403 abstracts), Psycinfo
(2,097), Embase (2,207), and the Cochrane Central Register of
Controlled Trials (2,204). We identified these abstracts by combining
terms indicative of psychological treatment (psychotherapy, psycho-
logical treatment, cognitive therapy, behaviour therapy, interpersonal
therapy, counselling, family therapy, marital therapy, problem-solving
therapy, psychodynamic therapy, psychoanalysis, relaxation, reminis-
cence, life review) and depression (both MeSH-terms and textwords).
For this database, we also collected the primary studies from 22 meta-
analyses of psychological treatment of depression.[1] We retrieved a
total of 857 papers for further study. These papers were studied, and
we selected the ones which examined the relative effects of
psychological and combined treatments of depression.
Second, references of earlier reviews and meta-analyses were
examined.[1,16–18,27–28] Finally, the references of retrieved papers were
checked.
We included studies in which (1) a psychological intervention (2)
was compared to a combined treatment (3) consisting of the same
psychological intervention plus an antidepressant, (4) in a rando-
mized trial, (5) aimed at subjects with depression (as diagnosed
through a clinical interview and/or a self-report questionnaire).
Psychological interventions were defined as treatments in which
verbal communication between a therapist and a client was the core
element and in which the communication of the therapist is based on
a specific theoretical framework about the causes of depression and
how the communication can reduce it. Studies were included when all
randomized participants had a depressive disorder (or scored above a
cut-off point on a self-report instrument); comorbid general medical
or psychiatric disorders were not used as an exclusion criterion. No
language restrictions or age limits were applied. We excluded studies
on maintenance treatments and studies in which a psychological
treatment plus placebo were compared to a psychological treatment
plus active antidepressant, because it cannot be ruled out that the
placebo has an effect in itself.
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QUALITY ASSESSMENT
At least 25 scales have been used to assess the validity and quality
of RCTs,[30] but evidence of their reliability and validity is lacking.
We adopted the Cochrane Handbook’s 4 criteria,[30] to assess study
validity: (1) randomization to conditions conducted by an indepen-
dent (third) party; (2) concealment of randomization to conditions;
(3) blinding of assessors of outcome; (4) completeness of follow-up
data.
ANALYSES
We directly compared the psychological and combined treatments
on depressive symptomatology (continuous outcomes), recovery
(dichotomous outcomes), and drop-out.
Effects on depressive symptomatology (continuous
outcomes). We calculated effect sizes indicating the difference
between psychological and combined treatments. The effect sizes (d)
were calculated by subtracting (at post-test) the average score of the
psychological treatment group (Mp) from the average score of the
combined treatment group (Mc) and dividing the result by the pooled
standard deviations of the experimental and control groups (SDpc).
An effect size of .5 thus indicates that the mean of the psychological
treatment group is half a standard deviation larger than the mean of
the combined treatment group. Effect sizes of .8 can be assumed to be
large, whereas effect sizes of .5 are moderate, and effect sizes of .2 are
small.[31] In the calculations of effect sizes, only those instruments
were used that explicitly measure depression (Table 1). If more than
one depression measure was used, the mean of the effect sizes was
calculated, so that each study (or contrast group) had only one effect
size. When means and standard deviations were not reported, we
used other statistics (t-value, p-value) to calculate effect sizes.
To calculate pooled mean effect sizes, we used the computer
program Comprehensive Meta-analysis (version 2.2.021), developed
for support in meta-analysis. We conducted all analyses using both
the fixed effects model and the random effects model.[25] As an
indicator of homogeneity, we calculated the Q-statistic. We also
calculated the I2-statistic, which is an indicator of heterogeneity in
percentages. A value of 0% indicates no observed heterogeneity, and
larger values show increasing heterogeneity, with 25% as low, 50% as
moderate, and 75% as high heterogeneity.
Subgroup analyses. We examined whether specific charac-
teristics of the studies were related to the effect sizes by using the
procedures for subgroup analyses as implemented in Comprehensive
Meta-analysis. In these analyses we used the mixed effects model.
This means that the random effects model is used to calculate the
effect size for each subgroup, whereas the fixed effects model tests the
difference between the subgroups of studies.
We conducted subgroup analyses on the selected characteristics of
the three core elements of the studies: participants, interventions, and
study characteristics. With regard to the participants we examined
the recruitment method (clinical samples versus other samples) and
target group (adults in general versus specific population). We also
examined the type of psychological intervention (CBT versus other
types of psychological treatments) and the type of pharmacological
treatment (tricyclics, SSRIs, or other). General characteristics of the
studies we reviewed in subgroup analyses were: drop out rate (less
than 20% drop-out versus 20% or more drop-out), type of analyses
(intention-to-treat analyses versus completers-only analyses), and the
period in which the study was conducted (before 1995 versus 1995 or
later).
Effects on recovery (dichotomous outcomes). We
calculated the relative risk (RR) of recovery in subjects receiving
psychological treatment compared to subjects receiving combined
treatment. Again, we conducted all meta-analyses both with the fixed
effects model and with the random effects model, using the
Comprehensive Meta-analysis (version 2.2.021) computer program,
and we calculated the Q-statistic and the I2-statistic to estimate
heterogeneity between study outcomes.
Publication bias. Publication bias was tested by inspecting
the funnel plot on primary outcome measures, and by Duval and
Tweedie’s trim and fill procedure, which yields an estimate of the
effect size after the publication bias has been taken into account (as
implemented in Comprehensive Meta-analysis, version 2.2.021).
We also calculated ‘‘Orwin’s fail safe N.’’ This number indicates
how many studies with an effect size of zero should be found to
reduce the effect size that is found to a lower value (for example, .10).
A larger N indicates that the effect size found can be further
generalized.
RESULTS
DESCRIPTION OF INCLUDED STUDIES
All inclusion criteria were met by 19 studies, with a
total of 1,838 subjects (934 in the psychological
treatment groups, and 904 in the combined treatment
groups). Selected characteristics of these studies are
described in Table 1.
Fourteen studies were aimed at adults in general, and
five at specific populations (two at adults with HIV; one
focused on multiple sclerosis patients; one on adults
with chronic depression; and one on older adults).
Eleven studies were aimed at clinical populations, six at
subjects recruited from the community, and two did
not report the recruitment method or they used
systematic screening to recruit patients. In all but one
study only subjects who met diagnostic criteria for a
depressive disorder (including two studies specifically
aimed at patients with dysthymia) were included. In
eight studies, CBT was used as psychological treat-
ment. In three studies, amitryptiline was used as the
antidepressant medication, in three other studies
imipramine was used, a further three had desipramine,
two had fluoxetine, and the remaining 12 used another
medication or used more than one type of medication.
Six studies were conducted before 1990, five between
1990 and 1999, and the remaining eight after 2000.
Seventeen studies were published in English, one in
Spanish, and one in German.
QUALITY OF THE INCLUDED STUDIES
The quality of the studies varied. Only four studies
reported that allocation to conditions was conducted
by an independent party. Concealment of random
allocation to respondents was not possible or not
reported in any of the studies, whereas blinding of
assessors was reported in 11 studies. Drop-out numbers
ranged from 6 to 55%.
CONTINUOUS OUTCOMES AT POST-TEST
In 17 studies (19 comparisons), effect sizes could be
calculated which indicated the difference between
psychological and combined treatments at post-test.
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The mean effect size indicating the difference between
psychological and combined treatments was .35 (95%
CI: .24.45; Po.001) both in the fixed and the random
effects model. Heterogeneity was very low (Q 5 15.85
n.s.; I2 5 0). The results of these analyses are summar-
ized in Table 2 and Figure 1.
Because the weight of one study was very high[21]
(28.50%), we also conducted a meta-analysis in which
this study was removed. The results were almost the
same (fixed effects and random effects model: d 5 .27;
95% CI: .15.39, Po.001; I2 5 0).
Two studies contained more than one comparison of
a psychological versus a combined treatment.[32,33] We
included the four comparisons from these studies in
our meta-analysis. Because these comparisons were not
independent of each other, we examined whether this
influenced the outcomes. We conducted a new meta-
analysis in which only the smallest effect size from each
of these two studies was included, but found that this
scarcely influenced the results (fixed effects and
random effects model: D 5 0.36; 95% CI: .25.46;
Z 5 6.56, Po.001; Q 5 15.39 n.s.; I2 5 0).
In 15 studies (17 comparisons), the Hamilton Rating
Scale for Depression (HRSD) was used. When only
this scale was used for the calculation of the effect sizes,
a mean effect size of .35 (95% CI: .24.46) was found
with the fixed effects model, and .31 (95% CI: .18.45)
with the random effects model (with low heterogeneity:
Q 5 19.73 n.s.; I2 5 18.91). The fifteen comparisons
using the Beck Depression Inventory (BDI) resulted in
a mean effect size of 0.28 (95% CI: 0.120.43), both
with the fixed and the random effects model (Q 5 9.86,
n.s.; I2 5 0).
SUBGROUP ANALYSES
We conducted several subgroup analyses (Table 2).
No significant difference was found between the effect
size of studies in which clinically referred patients were
examined and those in which subjects were recruited in
other ways (mostly through community recruitment).
We also found no difference between older (o1995)
and newer (41995) studies; between studies which
used intention-to-treat analyses and those using
completers-only analyses; and between studies with a
drop-out rate below 20% and those with a drop-out
rate of 20% or higher.
We found a significant difference (Po.05) between
studies which used cognitive behavioural intervention
and those in which other types of psychological
TABLE 2. Meta-analyses of studies comparing the effects of psychological treatments on depression compared to
combined treatments at post-test: continuous outcomes
Study Ncomp D 95% CI Z Q
a I2 P
Overall effects
All studies Fixed/random effectsb 19 0.35 0.24–0.45 6.67 15.85 0
All studies without Keller Fixed/random effectsb 18 0.27 0.15–0.39 4.37 10.18 0
Only HRSD Fixed effects 17 0.35 0.24–0.46 6.24 19.73 18.91
Random effects 0.31 0.18–0.45 4.59
Only BDI Fixed/random effectsb 15 0.28 0.12–0.43 3.55 9.86 0
Subgroup analysesc
Target group Adults 14 0.24 0.10–0.37 3.49 4.06 0 o
Specific groups 5 0.49 0.27–0.71 4.29 5.21 23.25
Recruitment Clinical 11 0.39 0.27–0.51 6.31 8.46 0 n.s.
Other 8 0.24 0.05–0.43 2.53 5.64 0
Psychological treatment CBT 8 0.15 0.06–0.37 1.39 1.97 0 
Other 11 0.40 0.29–0.52 6.82 9.95 0
Year of publication Before 1995 7 0.22 0.05–0.49 1.60 2.55 0 n.s.
1995 or later 12 0.35 0.23–0.47 5.62 12.35 10.92
Drop-out rated o20% 7 0.24 0.06–0.43 2.59 2.25 0 n.s.
4 20% 10 0.36 0.18–0.53 4.06 11.04 18.50
Analyses Intention-to-treat 12 0.39 0.26–0.52 6.00 11.15 1.34 n.s.
Completers-only 7 0.25 0.08–0.43 2.82 3.04 0
Medication category Tricyclics 10 0.22 0.02–0.41 2.21 5.47 0 o
SSRIs 6 0.27 0.08–0.45 2.83 3.82 0
Other 3 0.49 0.33–0.64 6.10 0.94 0
Effects at follow-up
3–6 months Fixed 1 randomb 3 0.15 0.58–0.27 0.71 n.s. 0.01 0
12 months Fixed 1 randomb 5 0.00 0.26–0.26 0.01 n.s. 1.87 0
o: Po0.10; Po0.05; Po0.01; Po 0.001.
aThe results for the random effects model and the fixed effects model were identical.
bAll subgroup analyses were conducted with mixed effects analyses.
cNone of the Q-values was significant (P40.05).
dthe two studies in which the drop-out rates were not reported were not included in these analyses.
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treatments were found (Table 2). For that comparison
the advantage of combination was less when medica-
tion was added to CBT. We also found a trend showing
that studies using tricyclic medications or SSRIs were
used had smaller effect sizes than studies using another
medication (nefazodone)[24] or more than one type of
medication.[22,41]
We found a trend (Po.1) indicating a significant
difference between studies aimed at adults with
depression and the effect size of studies targeting
specific populations (two studies on HIV-patients; one
study on adults with chronic depression, one on




The RR indicating the difference between psycho-
logical and combined treatments in recovery was .78
(95% CI: .710.860; 17 comparisons; Z 54.91;
Po.001), both in the fixed and the random effects
model. Heterogeneity was low (Q 5 12.90; n.s.; I2 5 0).
The results of these analyses are summarized in Table 3
and Figure 2.
We conducted the same subgroup analyses as with
the continuous outcomes (Table 3). However, none of
the variables we examined in these analyses resulted in
a significant difference between subgroups (including
the three variables that were found to be significant in
the analyses with the continuous outcomes).
PUBLICATION BIAS
Neither the funnel plots nor Duval and Tweedie’s
trim and fill procedure pointed at a significant
publication bias. And this was true both in the analyses
with the continuous outcomes and in the analyses with
the dichotomous outcomes. The effect size indicating
the difference in depressive symptomatology between
psychological treatment and combined treatment con-
ditions did not change after adjustment for possible
publication bias (the observed and adjusted d were
identical), and this was also true for the RR indicating
the difference between psychological and combined
treatments.
We then calculated Orwin’s fail-safe N, which is the
number of studies with an effect size of zero that should
be found to reduce the mean effect size (indicating the
difference between psychological and combined treat-
ments) to .10; this was found to be 44. The number of
studies (with an RR of 1) needed to reduce the RR from
0.78 to 0.90 was found to be 24.
EFFECTS AT FOLLOW-UP
In seven studies (10 comparisons) the difference
between psychological and combined treatments at
follow-up were presented. The results of these analyses
are presented in Table 2. The follow-up periods ranged
from 1 month to 2 years. As there was only one study
which reported the results at 2-year follow-up, this
study was not included in the analyses. Nor did we
include the study in which a follow-up of one month
was used.
Figure 1. Standardized effect sizes of psychological treatment for depression compared to combined treatment at post-test:
Continuous outcomes
284 Pim Cuijpers et al.
Depression and Anxiety
None of the analyses indicated a significant differ-
ence between psychological and combined treatments
at 3–6 months follow-up, and at 12 months follow-up.
Because of the small number of comparisons and the
differences in follow-up periods, we did not analyse the
results at follow-up any further.
DISCUSSION
We found clear evidence that a combined psycholo-
gical and pharmacological treatment of depression is
superior to psychological treatment alone in the short
term. This was true when we pooled different effect
TABLE 3. Meta-analyses of studies comparing the effects of psychological treatments on depression compared to
combined treatments at post-test: Dichotomous outcomes
Study N RR 95% CI Z Qa I2 P
Overall effects
All studies Fixed/random effectsb 17 0.78 0.71–0.86 4.91 12.90 0
Subgroup analysesc
Target group Adults 13 0.82 0.73–0.92 3.50 8.78 0 n.s.
Specific groups 4 0.67 0.55–0.82 3.81 1.43 0
Recruitment Clinical 10 0.78 0.69–0.88 4.02 3.21 0 n.s.
Other 7 0.71 0.49–1.02 1.86 9.68 38.04
Psychological treatment CBT 6 0.85 0.68–1.07 1.40 5.78 13.44 n.s.
Other 11 0.76 0.68–0.85 4.76 6.11 0
Year of publication Before 1995 8 0.83 0.67–1.02 1.81 6.73 0 n.s.
1995 or later 9 0.77 0.68–0.86 4.61 0
Drop-out rated o20% 7 0.80 0.68–0.93 2.92 4.25 0 n.s.
420% 9 0.77 0.67–0.90 3.41 8.52 6.06
Analyses Intention-to-treat 10 0.74 0.64–0.85 4.24 6.67 0 n.s.
Completers-only 7 0.82 0.72–0.95 2.69 5.06 0
Medication category Tricyclics 9 0.82 0.69–0.98 2.15 7.66 0 n.s.
SSRIs 5 0.80 0.69–0.94 2.82 2.76 0
Other 3 0.70 0.58–0.85 3.63 0.77 0
Po0.05; Po0.01; Po0.001.
aThe fixed effects model and the random effects model resulted in the same outcomes.
bAll subgroup analyses were conducted with mixed effects analyses.
cNone of the Q-values was significant.
dThe study in which the drop-out rates was not reported, was not included in these analyses.
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Figure 2. Standardized effect sizes of psychological treatment for depression compared to combined treatment at post-test:
Dichotomous outcomes
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sizes, but also when we examined specific outcome
measures. Heterogeneity was low in these analyses,
indicating that the studies, target populations, and
interventions are probably highly comparable to each
other. We found no indication of publication bias, and
fail-safe analyses showed that a large number of studies
with no difference would have to be found to reduce
the overall effects on a nonsignificant outcome. There-
fore, there should be little doubt that there is indeed a
difference in effects between psychological and com-
bined treatments. Because the effect size indicating the
difference between psychological and combined treat-
ments was small to moderate, several individual studies
failed to find a significant difference, and it is a clear
advantage of a meta-analytic approach that makes it
possible to combine the results of multiple studies and
validate such small effect sizes.
However, the effect size indicating the difference
between psychological and combined treatments is
small to moderate. Effect sizes lower than 0.30 are
usually considered to be small, and our effect size was
only just above that threshold (d 5 0.35). Although our
finding was statistically significant, it is not clear
whether this has any clinical relevance. To obtain an
idea of the clinical relevance of these effect sizes, the
use of the binomial effect size display is recom-
mended.[46,47] This displays the difference in success
rate between the two treatments. When we compare
psychological treatment to combined treatment, the
binomial effect size display (based on d 5 .35) indicates
that the success rate increases from .41 to .59. This
suggests that combined treatment is superior for some
patients and that combined treatment should be offered
to patients before psychological treatment alone is
considered.
However, these results should be considered with
caution. In our study, we did not examine the
comparative effects of pharmacotherapy and combined
treatment. Several studies have found that combined
treatment is more effective than pharmacotherapy
alone.[21,33,48,49] If this is indeed the case, then
combined treatment should be considered as a first
line treatment, as it is superior to both psychological
treatment alone and pharmacological treatment alone.
However, if pharmacotherapy appears to be equally
effective as combined treatment, it may be better to
consider pharmacotherapy first and only offer com-
bined treatment when pharmacotherapy alone does not
work. Because many patients prefer psychological
treatments and are not willing to take antidepres-
sants,[50] psychological treatments (without additional
pharmacotherapy) will remain an important part of
routine care, even when combined treatments are
clearly superior. More (meta-analytic) research is
needed to examine these questions.
One reason why the suggested superiority of
combined over psychological treatment alone should
be considered with caution is that no difference was
found in the longer term. This is probably at least in
part related to the small number of available effect sizes
at follow-up. It does mean that there is currently no
evidence that combined treatment is superior to
psychological treatment alone in the longer term.
Our findings should also be considered in the light of
the study’s limitations. First, we found that the quality
of a number of the examined studies was not optimal.
Although it is clearly inherent in studies of research on
psychological treatments that it is not possible to
conceal to subjects to which condition they are
assigned, many studies did not meet other major
quality criteria, such as assignment to conditions by
an independent person, and blinding of assessors.
Another important limitation of this meta-analysis is
that we were only able to include a relatively small
number of studies. Therefore, the results of our
analyses should be considered very cautiously.
This meta-analysis only reports about average
effects. However, the average patient does not exist,
and it is entirely possible that different types of patients
are best served by different treatment strategies. One
finding of this study is research on specific populations
found significantly larger differences between psycho-
logical and combined treatments than studies in adult
outpatients. It is possible that psychological treatments
are less effective in some of these populations, which
increases the effects of the added pharmacological
treatments. But it also possible that the relative effects
of psychological and combined treatments are related
to severity, chronicity, and comorbid psychiatric or
general medical disorder. More research is needed to
examine these issues.
We found a trend indicating that the difference
between psychological and combined treatments is
smaller when cognitive behavioral therapy is used
compared to other psychological treatments. It could
be possible that cognitive behavioral treatments have
stronger effects than other psychological treatments. In
that case, the additional value of the pharmacological
treatment may be limited. Although there is some
evidence that cognitive behavioral treatments are more
effective than other treatments,[2,51] the evidence is
certainly not conclusive.[52]
Although we did find that combined treatment is
more effective than psychological treatment alone,
more research is needed to examine this difference.
Further research is called for on the relative efficacy of
psychological and combined treatments in the longer
term. More basic research is needed required to explore
the mechanisms through which both treatments work.
And more clinical research is necessary to examine
which treatment or combination of treatments is
effective at in the longer term.
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